2024 annual financial data
Kalaris Therapeutics 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -55,256,000 USD and net income was -58,769,000 USD.
Operating cash flow was -67,705,000 USD.
Get free Kalaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -55,256,000 USD
- Net income
- -58,769,000 USD
- Operating cash flow
- -67,705,000 USD